Inventor

MALI VENKAT REDDY

US52 patents

⚠️ This page may combine multiple inventors who share the name “MALI VENKAT REDDY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MALI VENKAT REDDY

CHEMOCENTRYX INC

Compounds for treatment of PD-L1 diseases

Triaryl compounds for treatment of PD-L1 diseases

6-5 fused rings as C5a inhibitors

Immunomodulator compounds

6-5 fused rings as C5a inhibitors

Substituted anilines as CCR(4) antagonists

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors

5-5 fused rings as C5a inhibitors

Soluble C5aR antagonists

Substituted tetrahydropyrans as CCR2 modulators

Soluble C5aR antagonists

Substituted tetrahydropyrans as CCR2 modulators

Substituted anilines as CCR(4) antagonists

Substituted anilines as CCR(4) antagonists

Substituted anilines as CCR(4) antagonists

CCR6 compounds

Immunomodulator compounds

Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors

5-5 fused rings as C5a inhibitors

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

Combination therapy using C-C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors

Soluble C5aR antagonists

Substituted anilines as CCR(4) antagonists

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

CCR6 compounds

Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors

Deuterated compounds as immunomodulators

6-5 fused rings as C5a inhibitors

Prodrugs of fused-bicyclic C5aR antagonists

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

Triaryl compounds for treatment of PD-L1 diseases

Substituted tetrahydropyrans as CCR2 modulators

Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors

Substituted anilines as CCR(4) antagonists

Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2

Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2

CCR6 compounds

Indanes as PD-L1 inhibitors

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

METABASIS THERAPEUTICS INC

Antagonists of the glucagon receptor

Antagonists of the glucagon receptor

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

Antagonists of the glucagon receptor

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

GOMEZ-GALENO JORGE E

Antagonists of the glucagon receptor

REDDY K RAJA

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

ABBVIE INC

Pyrimidines for degrading Bruton&#39;s tyrosine kinase

Pyrimidines for degrading Bruton's tyrosine kinase